Prevention of disease progression throughout the cardiovascular continuum

Viac o knihe

Despite significant advancements in medicine, cardiovascular diseases continue to be the leading cause of death in the new millennium. The continuum of cardiovascular disease begins with risk factors like hypertension, diabetes, and lipid disorders, progressing to conditions such as coronary artery disease and left ventricular hypertrophy. Following initial myocardial damage, such as myocardial infarction, left ventricular dysfunction and remodeling occur, ultimately resulting in heart failure. This book provides a comprehensive overview of the impact of antiadrenergic treatment across various stages of the cardiovascular continuum, with a strong focus on heart failure, contributed by a team of prominent international clinical cardiologists. Key topics include the pathophysiology of the cardiovascular continuum and therapeutic targets, the effects of β-blockade on the cardiovascular system, the role of multiple adrenergic blockade in coronary artery disease, and the epidemiology and diagnostic challenges of heart failure. It also explores insights from clinical trials regarding the effectiveness of different β-blockers for heart failure, practical experiences with antiadrenergic treatment in daily practice, and official guidelines for optimal use. Finally, it discusses future directions in heart failure management, emphasizing the need for continued research and innovation in this critical area of healthcare.